Gastroenterol Res
Gastroenterology Research, ISSN 1918-2805 print, 1918-2813 online, Open Access
Article copyright, the authors; Journal compilation copyright, Gastroenterol Res and Elmer Press Inc
Journal website http://www.gastrores.org

Case Report

Volume 5, Number 3, June 2012, pages 130-132


An Acute Abdominal Catastrophe in a HIV Positive Patient

Vinaya Gaduputia, Harish Patela, Vamshidhar Vootlaa, Usman Khana, b, Sridhar Chilimuria

aBronx Lebanon Hospital Center, Department of Medicine, 1650 Selwyn Ave, Suit #10C, Bronx, New York 10457, USA
bCorresponding author: Usman Khan

Manuscript accepted for publication June 13, 2012
Short title: Acute Abdominal Catastrophe
doi: https://doi.org/10.4021/gr451w

Abstract▴Top 

We report this case of a 45-year-old man with HIV-AIDS on HAART therapy who presented with acute abdominal pain and renal failure. He was found to have pneumatosis intestinalis on computerized axial tomography scan of the abdomen. He underwent emergent explorative laparotomy, which revealed a necrotic large bowel segment for which a right-sided hemicolectomy and ileostomy were performed. The patient subsequently developed septic shock and hypoxic respiratory failure. He expired a week after the surgical procedure. Acute abdominal events due to vascular catastrophes secondary to hypercoagulability, endothelial dysfunction and accelerated atherosclerosis have been reported in HIV positive patients.

Keywords: Acute abdomen; HIV

Introduction▴Top 

Longevity of the patients infected with HIV has increased since the introduction of Highly Active Antiretroviral Therapy (HAART). However, many patients on HAART therapy develop long-term metabolic derangements such as dyslipidemia, diabetes mellitus and insulin resistance [1-3]. HAART therapy and HIV infection in itself, produce chronic inflammation and cellular homeostatic stress response cascade [4] .It has been postulated that the increased cardiovascular risk is the result of HIV induced direct viral injury, endothelial dysfunction, hypercoagulabilty [5, 6]; opportunistic infections induced vaso-occlusive disease (especially CMV) [7] or chronic inflammatory state [8]. HIV induced large-vessel related catastrophes have been reported in the literature, including acute abdomen resulting from intestinal ischemia. The review of literature has shown this to happen usually as a result of atherogenic lipid profile (induced by HIV, HAART therapy or both) [9] or direct vaso-occlusive effect of opportunistic infections such as CMV. We postulate that subclinical atherosclerosis (as observed in Carotid and Coronary Intima media thickening (IMT) measurement studies [10] of the mesenteric arterial tree with superimposed hypercoagulabilty has a potential to produce critical ischemia, in presence of a precipitating cause such as renal failure or sepsis. We present one such unusual presentation of mesenteric ischemia probably secondary to such atherosclerosis.

Case Report▴Top 

A 56-year-old Hispanic man with HIV-AIDS, hypertension and deep vein thrombosis (DVT) on Warfarin presented to the Emergency Room with severe midline low back pain and right sided flank pain. Physical examination revealed stable vital signs, oral thrush and unremarkable cardiopulmonary, abdominal examination. The computerized axial tomography (CAT) scan of the abdomen revealed no acute intra-abdominal pathology. However, CAT scan revealed osteoporosis with central endplate depression of L5 vertebra. Magnetic Resonance Imaging (MRI) of the lumbosacral spine failed to reveal any acute pathology but did show degenerative changes, bridging osteophytes. The patient was treated for musculoskeletal pain with opiate analgesics and oral thrush with Fluconazole, while continuing the HAART therapy. Subsequently, patient developed acute renal failure on the third day of hospitalization (serum creatinine increased from 1.3 mg/dL to 2 mg/dL) which worsened further acutely over the course of the next 24 hours (serum creatinine increased from 2 mg/dL to 7.9 mg/dL) with development of severe hyperkalemia (6.4). Patient’s HAART therapy and other nephrotoxic medications (Lisinopril, Allopurinol) were held. On the fourth day of hospitalization, patient developed diffuse abdominal pain and worsening constipation. A Computerized Tomogram of the abdomen revealed signs of bowel obstruction, pneumatosis intestinalis and free air in the mesenteric and portal venous systems (Fig. 1-3). The patient underwent emergent explorative laparotomy that revealed necrotic bowel that required right-sided hemicolectomy and ileostomy. Patient subsequently developed septic shock and died on the thirteenth day of hospitalization.

Figure 1.
Click for large image
Figure 1. Coronal section of a Non-Contrast CAT scan of the abdomen revealing mural gas lucencies (black arrow) in the cecum, ascending and proximal portion of the transverse colon suggestive of extensive bowel necrosis.

Figure 2.
Click for large image
Figure 2. Coronal section of a Non-Contrast CAT scan of the abdomen revealing mural gas lucencies (white arrows) in the cecum, ascending and proximal portion of the transverse colon suggestive of extensive bowel necrosis.

Figure 3.
Click for large image
Figure 3. Transverse Section of a non-contrast CAT scan of abdomen showing the air bubble in the portal vein.
Discussion▴Top 

We present a middle-aged man with history of HIV-AIDS who presented with an acute mesenteric ischemia. Differential diagnoses of such presentation include: 1) mesenteric ischemia from an acute thrombotic event; 2) mesenteric ischemia resulting from vasocclusive opportunistic infections such as CMV; 3) mesenteric ischemia from an atheroembolic event; 4) an undiagnosed thrombophilia; 5) Non-occlusive mesenteric ischemia (NOMI) and 6) subclinical atherosclerosis with superimposed acute systemic insults such as renal failure and sepsis. Mesenteric ischemia from an acute thrombotic event as result of hypercoagulabilty is possible in HIV positive patients. Patient already had an episode of venous thrombosis in the past and was on an anticoagulation medication. The patient at the time of presentation was adequately anticoagulated. Mesenteric ischemia from an acute thrombotic event or an undiagnosed thrombophilia being the cause of this presentation is extremely unlikely in the setting of supra-therapeutic INR (5.5) of the patient. Opportunistic infections such as CMV would also have been unlikely, as patient’s CD4 T-helper cells count was above 150.

Though Protease Inhibitors are notorious for causing lipid panel anomalies and endothelial dysfunction [4], an atheroembolic cause is not probable in the setting of patient’s near normal lipid panel. A more direct evidence of this came from surgical pathology where the mesenteric vessels were found to be atherosclerotic but did not reveal any occlusive atheroma or thrombus. Also, there were no other evidences of metabolic syndrome or lipodystrophy seen with chronic protease inhibitor therapy. Nonocclusive mesenteric ischemia often presents with watershed zone ischemia. However, it is usually associated with hypovolemia, episodes of hypotension and precipitating drugs such as diuretics or vasoconstrictors, none of which were present in this patient [11]. However, NOMI has been found to be often associated with renal failure, such as found in this patient. Subclinical atherosclerosis produced by direct viral injury or metabolic effects of the HAART, superimposed by acute splanchnic vasoconstriction in response to acute renal failure and sepsis could have produced the clinical scenario as seen in this patient. Given the fact that he had acute renal failure, which is associated with NOMI and was on HAART therapy for HIV, which is known to be atherogenic as demonstrated by his atherosclerotic mesenteric vessels, mesenteric ischemia might have resulted from a combination of both the etiologies. With increasing use of HAART medications and increasing prevalence of resultant metabolic derangements, mesenteric ischemia should be seriously considered in patients presenting with acute abdomen.

Disclosure

None.

Authors’ Contributions

All Authors have made contributions to the article and have reviewed it before submission.


References▴Top 
  1. Boufassa F, Goujard C, Viard JP, Carlier R, Lefebvre B, Yeni P, Bouchaud O, et al. Immune deficiency could be an early risk factor for altered insulin sensitivity in antiretroviral-naive HIV-1-infected patients: the ANRS COPANA cohort. Antivir Ther. 2012;17(1):91-100.
    pubmed doi
  2. Alencastro PR, Fuchs SC, Wolff FH, Ikeda ML, Brandao AB, Barcellos NT. Independent predictors of metabolic syndrome in HIV-infected patients. AIDS Patient Care STDS. 2011;25(11):627-634.
    pubmed doi
  3. Gutierrez AD, Balasubramanyam A. Dysregulation of glucose metabolism in HIV patients: epidemiology, mechanisms, and management. Endocrine. 2012;41(1):1-10.
    pubmed doi
  4. Hurlimann D, Weber R, Enseleit F, Luscher TF. [HIV infection, antiretroviral therapy, and endothelium]. Herz. 2005;30(6):472-480.
    pubmed doi
  5. Musselwhite LW, Sheikh V, Norton TD, Rupert A, Porter BO, Penzak SR, Skinner J, et al. Markers of endothelial dysfunction, coagulation and tissue fibrosis independently predict venous thromboembolism in HIV. AIDS. 2011;25(6):787-795.
    pubmed doi
  6. Francisci D, Giannini S, Baldelli F, Leone M, Belfiori B, Guglielmini G, Malincarne L, et al. HIV type 1 infection, and not short-term HAART, induces endothelial dysfunction. AIDS. 2009;23(5):589-596.
    pubmed doi
  7. Mulder R, Tichelaar YI, Sprenger HG, Mulder AB, Lijfering WM. Relationship between cytomegalovirus infection and procoagulant changes in human immunodeficiency virus-infected patients. Clin Microbiol Infect. 2011;17(5):747-749.
    pubmed doi
  8. Kiser KL, Badowski ME. Risk factors for venous thromboembolism in patients with human immunodeficiency virus infection. Pharmacotherapy. 2010;30(12):1292-1302.
    pubmed doi
  9. De Lorenzo F, Collot-Teixeira S, Boffito M, Feher M, Gazzard B, McGregor JL. Metabolic-inflammatory changes, and accelerated atherosclerosis in HIV patients: rationale for preventative measures. Curr Med Chem. 2008;15(28):2991-2999.
    pubmed doi
  10. Tabib A, Leroux C, Mornex JF, Loire R. Accelerated coronary atherosclerosis and arteriosclerosis in young human-immunodeficiency-virus-positive patients. Coron Artery Dis. 2000;11(1):41-46.
    pubmed doi
  11. Wilcox MG, Howard TJ, Plaskon LA, Unthank JL, Madura JA. Current theories of pathogenesis and treatment of nonocclusive mesenteric ischemia. Dig Dis Sci. 1995;40(4):709-716.
    pubmed doi


This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Gastroenterology Research is published by Elmer Press Inc.

 
Home     |     Log In     |      About     |      Search     |      Current     |      Archives     |      Submit      |     Subscribe


 

     

Aims and Scope

Current Issues

Conflict of Interest

About Publisher

Editorial Board

Archives

Copyright

Company Profile

Editorial Office

Misconduct and Retraction

Permissions

Company Registration

Contact Us

Abstracting and Indexing

ICMJE

Ownership

Instructions to Authors

Access

Declaration of Helsinki

Contact Publisher

Submission Checklist

Reprints

Terms of Use

Company Address

Submit a Manuscript

Open Access Policy

Privacy Policy

Browse Journals

Publishing Fee

Publishing Policy

Disclaimer

Recent Highlights

Peer-Review Process

Publishing Quality

Code of Ethics

Advertising Policy

Manuscript Tracking

Advanced Search

For Librarians

Careers

Publishing Process

Publication Frequency

For Reviewers

Propose a New Journal

       
       

Gastroenterology Research, bimonthly, ISSN 1918-2805 (print), 1918-2813 (online), published by Elmer Press Inc.        
The content of this site is intended for health care professionals.

This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)


This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.gastrores.org   editorial contact: editor@gastrores.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.

DECLARATION: THIS JOURNAL SITE OUTLOOK IS DESIGNED BY THE PUBLISHER AND COPYRIGHT PROTECTED. DO NOT COPY!